Brima M. Younis
University of Khartoum(SD)
Publications by Year
Research Areas
Research on Leishmaniasis Studies, Trypanosoma species research and implications, Parasites and Host Interactions, Cytokine Signaling Pathways and Interactions, Insect and Pesticide Research
Most-Cited Works
- → Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study(2010)117 cited
- → Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial(2014)100 cited
- → Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial(2011)71 cited
- → Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial(2022)67 cited
- → Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan(2021)64 cited
- → The Economic Burden of Visceral Leishmaniasis in Sudan: An Assessment of Provider and Household Costs(2013)47 cited
- → Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines(2012)37 cited
- → Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa(2021)35 cited
- → Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study(2017)35 cited
- → Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study(2023)33 cited